Get started
ORGANON & COORGANON & COORGANON & CO

ORGANON & CO

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1OGN chart


Full chart

1OGN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.29 B‬EUR
Dividend yield (indicated)
6.20%
Price to earnings Ratio (TTM)
3.585
Basic EPS (TTM)
4.555EUR
Net income (FY)
‪926.85 M‬EUR
Revenue (FY)
‪5.67 B‬EUR
Shares float
‪256.91 M‬
Beta (1Y)
0.23

Employees


Employees (FY)
‪10 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪626.30 K‬EUR
Net income / Employee (1Y)
‪102.30 K‬EUR

About Organon & Co.


Sector
Health Technology
CEO
Kevin Ali
Headquarters
Jersey City
Website
organon.com
Founded
2020
FIGI
BBG01K3WCTQ5
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

1OGN news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1OGN highest yielding bonds


MRK5808585
Organon & Co. 7.875% 15-MAY-2034
Yield to maturity
7.24%
Maturity date
May 15, 2034
MRK5164077
Organon Finance 1 LLC 5.125% 30-APR-2031
Yield to maturity
6.80%
Maturity date
Apr 30, 2031
MRK5808583
Organon & Co. 6.75% 15-MAY-2034
Yield to maturity
6.68%
Maturity date
May 15, 2034
MRK5164075
Organon Finance 1 LLC 4.125% 30-APR-2028
Yield to maturity
5.32%
Maturity date
Apr 30, 2028
XS233225070
ORGANON/ORG.F. 21/28 REGS
Yield to maturity
3.94%
Maturity date
Apr 30, 2028

Explore more bonds 

Frequently Asked Questions


The current price of 1OGN is 16.710 EUR — it has increased by 0.15% in the past 24 hours. Watch ORGANON & CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ORGANON & CO stocks are traded under the ticker 1OGN.
1OGN stock has risen by 8.61% compared to the previous week, the month change is a 1.95% rise, over the last year ORGANON & CO has showed a 52.88% increase.
We've gathered analysts' opinions on ORGANON & CO future price: according to them, 1OGN price has a max estimate of 27.69 EUR and a min estimate of 15.69 EUR. Watch 1OGN chart and read a more detailed ORGANON & CO stock forecast: see what analysts think of ORGANON & CO and suggest that you do with its stocks.
1OGN reached its all-time high on Jul 31, 2024 with the price of 21.710 EUR, and its all-time low was 10.000 EUR and was reached on Dec 8, 2023. View more price dynamics on 1OGN chart.
See other stocks reaching their highest and lowest prices.
1OGN stock is 0.15% volatile and has beta coefficient of 0.23. Track ORGANON & CO stock price on the chart and check out the list of the most volatile stocks — is ORGANON & CO there?
Today ORGANON & CO has the market capitalization of ‪4.28 B‬, it has increased by 3.83% over the last week.
Yes, you can track ORGANON & CO financials in yearly and quarterly reports right on TradingView.
ORGANON & CO is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
1OGN earnings for the last quarter are 0.78 EUR per share, whereas the estimation was 0.81 EUR resulting in a −3.70% surprise. The estimated earnings for the next quarter are 0.85 EUR per share. See more details about ORGANON & CO earnings.
ORGANON & CO revenue for the last quarter amounts to ‪1.42 B‬ EUR, despite the estimated figure of ‪1.40 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.46 B‬ EUR.
1OGN net income for the last quarter is ‪322.43 M‬ EUR, while the quarter before that showed ‪182.05 M‬ EUR of net income which accounts for 77.11% change. Track more ORGANON & CO financial stats to get the full picture.
Yes, 1OGN dividends are paid quarterly. The last dividend per share was 0.25 EUR. As of today, Dividend Yield (TTM)% is 6.20%. Tracking ORGANON & CO dividends might help you take more informed decisions.
ORGANON & CO dividend yield was 7.77% in 2023, and payout ratio reached 28.06%. The year before the numbers were 4.01% and 31.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪10.00 K‬ employees. See our rating of the largest employees — is ORGANON & CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANON & CO EBITDA is ‪1.58 B‬ EUR, and current EBITDA margin is 24.96%. See more stats in ORGANON & CO financial statements.
Like other stocks, 1OGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANON & CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORGANON & CO technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORGANON & CO stock shows the strong sell signal. See more of ORGANON & CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.